Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy
- Conditions
- Benign Laparoscopic HysterectomySystematic Salpingectomy
- Interventions
- Other: Histopathologic tube anomalies
- Registration Number
- NCT03921138
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
In this prospective study, patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy were included. The aim of this study is to assess the prevalence of tubal histopathological abnormalities such as Serous Tubal Intraepithelial Carcinoma (STIC) and tumor protein 53 (p53) signatures) as well as the prevalence of perioperative and postoperative complications related to opportunistic laparoscopic salpingectomy in a low risk population. The hypothesis is that prophylactic salpingectomy during benign laparoscopic hysterectomy is both feasible and innocuous. Peri- and postoperative complications, duration of salpingectomy and post-salpingectomy blood loss, histopathological and immunohistochemical analysis with anti-p53 antibody were evaluated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 100
- patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy
- Hysterectomy in a context of gynecologic cancer
- Hysterectomy not carried out using laparoscopy
- Fimbriated end missing or damaged or impossible for pathologist to analyze
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Benign laparoscopic hysterectomy Histopathologic tube anomalies Patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy
- Primary Outcome Measures
Name Time Method Histopathologic tube anomalies day 1 of surgery Prevalence of histopathologic tube anomalies (Serous Tubal Intraepithelial Carcinoma STIC or tumor protein 53 (p53) lesion)
- Secondary Outcome Measures
Name Time Method